Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation
Open Access
- 14 April 2009
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (15) , 6321-6326
Abstract
HIV-1 latency in resting CD4 + T cells represents a major barrier to virus eradication in patients on highly active antiretroviral therapy (HAART). Eliminating the latent HIV-1 reservoir may require the reactivation of viral gene expression in latently infected cells. Most approaches for reactivating latent HIV-1 require nonspecific T cell activation, which has potential toxicity. To identify factors for reactivating latent HIV-1 without inducing global T cell activation, we performed a previously undescribed unbiased screen for genes that could activate transcription from the HIV-1 LTR in an NF-κB-independent manner, and isolated an alternatively spliced form of the transcription factor Ets-1, ΔVII-Ets-1. ΔVII-Ets-1 activated HIV-1 transcription through 2 conserved regions in the LTR, and reactivated latent HIV-1 in cells from patients on HAART without causing significant T cell activation. Our results highlight the therapeutic potential of cellular factors for the reactivation of latent HIV-1 and provide an efficient approach for their identification.Keywords
This publication has 32 references indexed in Scilit:
- Hide-and-Seek: The Challenge of Viral Persistence in HIV-1 InfectionAnnual Review of Medicine, 2008
- Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T CellsPLOS Pathogens, 2006
- The two NF-κB activation pathways and their role in innate and adaptive immunityTrends in Immunology, 2004
- Molecular Characterization, Reactivation, and Depletion of Latent HIVImmunity, 2003
- Transcriptional Profiles of Latent Human Immunodeficiency Virus in Infected Individuals: Effects of Tat on the Host and ReservoirJournal of Virology, 2003
- Structural Studies of Ets-1/Pax5 Complex Formation on DNAMolecular Cell, 2001
- Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyAIDS, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Defective activation and survival of T cells lacking the Ets-1 transcription factorNature, 1995
- An inducible transcription factor activates expression of human immunodeficiency virus in T cellsNature, 1987